Trinity Life Sciences
Trinity Life Sciences is a tech-enabled commercialization consultancy serving pharma, biotech, and medtech companies across global markets since 1996.
Founded in 1996, Trinity Life Sciences has established itself as a strategic, tech-enabled commercialization partner for the pharmaceutical, biotech, and medtech sectors. The firm's work spans the full lifecycle of medical innovation - from development through launch and ongoing optimization - serving over 350 industry-leading customers across North America, Europe, Latin America, and Asia Pacific.
The company's influence on the industry is substantial: Trinity has been involved in approximately 70% of all new drug launches, and its predictive models achieve accuracy rates of up to 90% on revenue outcomes. This track record reflects a methodology that combines deep human expertise with advanced artificial intelligence and analytics, underpinned by proprietary technology platforms including TrinityEDGE™ and InsightsEDGE™.
Trinity's technical capabilities extend across real-world evidence, analytics, and dedicated technology platforms - disciplines that sit at the intersection of data science and commercial strategy. For professionals drawn to rigorous, evidence-based work at scale, the firm offers a rare vantage point on how life sciences products reach the market and succeed within it.